Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects
Ageing Research Reviews · 2025-03 · 105 · 102689
DOI: 10.1016/j.arr.2025.102689 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2025-03. Verfasst von Bushra Bashir und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, India. Hauptthemen laut MEDLINE: Alzheimer Disease, Gastrointestinal Microbiome, Probiotics, Aging. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 236 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Aging is an extremely significant risk associated with neurodegeneration. The most prevalent neurodegenerative disorders (NDs), such as Alzheimer's disease (AD) are distinguished by the prevalence of proteinopathy, aberrant glial cell activation, oxidative stress, neuroinflammation, defective autophagy, cellular senescence, mitochondrial dysfunction, epigenetic changes, neurogenesis suppression, increased blood-brain barrier permeability, and intestinal dysbiosis that is excessive for the patient's age. Substantial body studies have documented a close relationship between gut microbiota and AD, and restoring a healthy gut microbiota may reduce or even ameliorate AD symptoms and progression. Thus, control of the microbiota in the gut has become an innovative model for clinical management of AD, and rising emphasis is focused on finding new techniques for preventing and/or managing the disease. The etiopathogenesis of gut microbiota in driving AD progression and supplementing postbiotics as a preventive and therapeutic treatment for AD is discussed. The review additionally discusses the use of postbiotics in AD prophylaxis and therapy, portraying them as substances that address senescence-triggered dysfunctions and are worthy of translating from bench to biopharmaceutical market in response to "silver consumers" needs. The current review examines and evaluates the impact of postbiotics as whole and specific metabolites, such as short-chain fatty acids (SCFAs), lactate, polyamines, polyphenols, tryptophan metabolites, exopolysaccharides, and bacterial extracellular vesicles, on the aging-associated processes that reinforce AD. Moreover, it provides an overview of the most recent data from both clinical and preclinical research involving the use of postbiotics in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, India.
- Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 140401, India; Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emi…
- Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA.
- Centre of Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences, Sydney, NSW 2007, Australia.
- School of Pharmacy, International Medical University, Kuala Lumpur 57000, Malaysia.
- Precision Medicine and Integrated Nano-Diagnostics (P-MIND) Research Group, Office of the Dean, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
Zitieren
APA
Bashir, B., Gulati, M., Vishwas, S., Gupta, G., Dhanasekaran, M., Paudel, K. R., Chellappan, D. K., Anand, K., Negi, P., Singh, P. K., Rajput, A., Dua, K., & Singh, S. K. (2025). Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects. Ageing Research Reviews, 105, 102689. https://doi.org/10.1016/j.arr.2025.102689
Vancouver
Bashir B, Gulati M, Vishwas S, Gupta G, Dhanasekaran M, Paudel KR, et al. Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects. Ageing Research Reviews. 2025;105:102689. doi:10.1016/j.arr.2025.102689
BibTeX
@article{Bashir2025,
author = {Bashir, Bushra and Gulati, Monica and Vishwas, Sukriti and Gupta, Gaurav and Dhanasekaran, Muralikrishnan and Paudel, Keshav Raj and Chellappan, Dinesh Kumar and Anand, Krishnan and Negi, Poonam and Singh, Pankaj Kumar and Rajput, Amarjitsing and Dua, Kamal and Singh, Sachin Kumar},
title = {Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects},
journal = {Ageing Research Reviews},
year = {2025},
volume = {105},
pages = {102689},
doi = {10.1016/j.arr.2025.102689}
}
EUVIMED